How Would You Manage This Patient With <i>Clostridioides difficile</i> Infection? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 37549387.
- Also identified by DOI 10.7326/M23-0754.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Infectious Diseases Society of America/Society for Healthcare Epidemiology of America and the American College of Gastroenterology recently released updated guidelines on management of patients with <i>Clostridioides difficile</i> infection. Although these 2 guidelines generally agree, there are a few important differences in their advice to clinicians. In these rounds, 2 experts, an infectious diseases specialist and a gastroenterologist, discuss antibiotic treatment options for nonsevere disease, the role of fecal microbiota transplantation for fulminant disease, and the use of bezlotoxumab to prevent recurrence in the context of Ms. C, a 48-year-old woman with fulminant <i>C difficile</i> infection.
Medical subject headings
- Clostridium Infections
- Clostridioides difficile